ICCB-280

N/A

Report date: 2023/03/13 10:45:41
NME

Base Information

Drug NameICCB-280
Drug Alias NameICCB-280
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCCAAT/enhancer-binding protein alpha inducers
TargetsCCAAT/enhancer-binding protein alpha
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesHarvard University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A